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Abstract
In most bacteria, Clp protease is a conserved, non-essential serine protease that regulates the response to various stresses.
Mycobacteria, including Mycobacterium tuberculosis (Mtb) and Mycobacterium smegmatis, unlike most well studied
prokaryotes, encode two ClpP homologs, ClpP1 and ClpP2, in a single operon. Here we demonstrate that the two proteins
form a mixed complex (ClpP1P2) in mycobacteria. Using two different approaches, promoter replacement, and a novel
system of inducible protein degradation, leading to inducible expression of clpP1 and clpP2, we demonstrate that both
genes are essential for growth and that a marked depletion of either one results in rapid bacterial death. ClpP1P2 protease
appears important in degrading missense and prematurely terminated peptides, as partial depletion of ClpP2 reduced
growth specifically in the presence of antibiotics that increase errors in translation. We further show that the ClpP1P2
protease is required for the degradation of proteins tagged with the SsrA motif, a tag co-translationally added to
incomplete protein products. Using active site mutants of ClpP1 and ClpP2, we show that the activity of each subunit is
required for proteolysis, for normal growth of Mtb in vitro and during infection of mice. These observations suggest that the
Clp protease plays an unusual and essential role in Mtb and may serve as an ideal target for antimycobacterial therapy.
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Introduction
Intracellular protein degradation is critical for maintaining
cellular homeostasis through protein quality control and regulation
of numerous biological pathways [1,2]. In eukaryotes, the
ubiquitin-proteasome pathway constitutes the predominant deg-
radation pathway [3]. Most prokaryotes, however, possess a
variety of ATP-dependent serine protease complexes, such as Lon
and Clp protease [4], and some actinomycetes and archaea
contain proteasomes, which are threonine proteases. Interestingly,
Mycobacterium tuberculosis (Mtb) encodes both a proteasome and Clp
protease. While recent work has explored the role of the Mtb
proteasome [5–7], little is known about mycobacterial Clp
protease. This serine protease was first discovered and is best
characterized in Escherichia coli [8,9]. The Clp proteolytic complex
is formed by the association of proteolytic subunits, ClpP, with
ATPase adapters, ClpX or ClpA in Gram-negative organisms and
ClpX or ClpC in Gram-positive organisms. E. coli ClpP is a
tetradecamer composed of two stacked heptameric rings of
identical ClpP subunits that form an internal proteolytic chamber
[10]. This core associates with distinct hexameric ATPase
adapters, ClpX and ClpC1 in mycobacteria, which provide
substrate specificity and catalyze ATP-dependent unfolding of
globular proteins [11,12]. In E. coli, the ClpXP protease is involved
in the regulation of the DNA damage response and degradation of
SsrA-tagged peptides stalled on the ribosome [13,14]. Clp
proteolytic enzymes are also required for full virulence in several
pathogenic organisms, including Listeria monocytogenes where the
protease is required for the production of a-listeriolysin [15,16]. In
most bacteria including E. coli, Clp protease is dispensable for
normal growth, and in fact, until recently, the only organism in
which clpP has been found to be essential is Caulobacter crescentus,
where Clp degrades CtrA, an inhibitor of cell cycle progression
[17].
Unlike most bacteria, which have a single ClpP subunit, the
genome of Mtb encodes two closely related ClpP homologs, clpP1
and clpP2, in a single operon. A transposon-based mutagenesis
screen for essential genes in Mtb predicted that ClpP2 and the
ATPase adapters ClpC1 and ClpX, were required for normal
growth [18] while a recent publication has shown that ClpP1 is
essential [19]. Here, we show that both ClpP1 and ClpP2 are
required for growth, and that their activity is important for the
removal of abnormal proteins. Our data suggest that ClpP1 and
ClpP2 assemble to form a single proteolytic complex, referred to as
PLoS Pathogens | www.plospathogens.org 1 February 2012 | Volume 8 | Issue 2 | e1002511ClpP1P2, that is required for normal growth in vitro and during
infection. In related studies, we have found that although pure
ClpP1 and ClpP2 by themselves form tetradecamers, they are
inactive. However, in the presence of low molecular weight
activators they reassociate to form a mixed tetradecamer,
ClpP1P2, which is capable of proteolysis (Akopian et. al.,
manuscript submitted). The unusual properties of this heteromeric
complex, the absence of such an enzyme in the eukaryotic
cytoplasm, and the essentiality of both subunits make ClpP1P2
protease an attractive target for novel therapeutic development for
the treatment of tuberculosis.
Results
ClpP1 and ClpP2 subunits interact to form a single
proteolytic complex
Mycobacterial genomes contain two homologous ClpP protease
genes, clpP1 and clpP2, arranged in a putative operon. To
investigate whether the two proteins may function together in a
complex, we co-expressed Mtb clpP1 and clpP2, each containing a
different C terminal epitope tag, in Mycobacterium smegmatis (Msm).
We used affinity chromatography with nickel resin to isolate 66-
His tagged Mtb ClpP2 together with associated proteins from the
Msm cell lysate. As shown in Figure 1A, a fraction of the c-myc
tagged ClpP1 bound to the Ni column and co-eluted with ClpP2.
To verify that ClpP1 and ClpP2 co-eluted from the Ni column
may be associated in a complex, we applied the fraction from the
Ni column containing both proteins to an anti-c-myc agarose
column and analyzed by SDS PAGE. Figure 1B shows that a
large fraction of the ClpP2 was associated with ClpP1.
Incidentally, expression of the Mtb proteins in Msm also led to
the co-isolation of Msm ClpP1 and ClpP2, as shown by tandem
mass spectrometry of the purified complex. In each case, peptides
present uniquely in Mtb or Msm ClpP1 and ClpP2 were detected
(Figure 1C).
If ClpP1 and ClpP2 do in fact associate to form a single
proteolytic core, we reasoned that mutations blocking the catalytic
activity of one subunit might reduce that activity of the enzyme.
We identified likely active site residues of ClpP1 and ClpP2 by
mapping the Mtb proteins onto E. coli ClpP and locating the
catalytic triad of Asp-His-Ser, which is characteristic of serine
proteases. In both cases, the serine likely to be responsible for
nucleophillic attack was replaced by an alanine (ClpP1 S98A and
ClpP2 S110A). To analyze the effects of these mutations, we
expressed and purified 66His-tagged forms of each protein,and
assayed their effect on the enzymatic activity of the wild type
ClpP1P2 in an in vitro peptidase assay (Akopian et. al., manuscript
submitted). Enzyme activity of the reconstituted ClpP1P2 complex
was quantified using cleavage of the fluorescence reporter, Z-Gly-
Gly-Leu-AMC. As seen in Figure 1D, addition of an excess of
mutated ClpP1 or ClpP2 to the active wild type ClpP1P2 complex
inhibited proteolytic cleavage of a fluorescent peptide substrate,
presumably by replacing the wild type subunits. These results
suggest that the ClpP1 and ClpP2 subunits interact to form a
single proteolytic complex in vitro, that each active site is important
for activity, and that these mutations can be used as dominant
negative inhibitors.
Both ClpP1 and ClpP2 are required for normal growth in
vitro
We employed three complementary strategies to determine if
ClpP1 and ClpP2 are required for normal growth in mycobac-
teria. First, using mycobacterial recombineering [20], we replaced
the endogenous promoter of clpP1 and clpP2 in Msm with a
tetracycline-inducible promoter (Figure 2A, Figure S1). Intro-
duction of a tetracycline repressor resulted in a strain
(ptet_clpP1P2) that could only be maintained in the presence of
the inducer anhydrotetracycline (ATc) (Figure 2B). In the
absence of this compound, growth did not occur, but could be
restored by the presence of an episomal plasmid containing both
clpP1 and clpP2. Plasmids expressing only clpP1 or clpP2 alone
could not rescue growth and depletion of either subunit resulted in
bacterial death (Figure 2C). Since complementation was
conducted with Mtb homologs and subunits from different species
associate into a functional tetradecamer, the ClpP1P2 complex is
likely very similar in Msm and Mtb. Furthermore, active site
mutants of either ClpP1 or ClpP2 were unable to complement
ptet_clpP1P2 in the absence of ATc, suggesting that the activity of
both subunits were required for normal growth (data not shown).
Second, we inserted a tetracycline inducible promoter upstream
of the clpP1P2 operon via homologous recombination in Msm
creating a strain in which clpP2 was inducibly expressed
(Figure 2D), and clpP1 was under the control of its native
promoter (ptet_clpP2). In accord with the previous findings, the
growth of this strain was dramatically inhibited in the absence of
ATc (Figure 2E).
Third, we used a system of inducible protein degradation
recently developed in Msm (Figure 3A) [21]. Briefly, we
employed mycobacterial recombineering to add an inducible
degradation (ID) tag to the C-terminus of ClpP2 (clpP2_ID). Upon
cleavage of the tag by a tetracycline inducible HIV-2 protease, an
SsrA sequence is revealed on the substrate that directs degradation
of the protein. By inserting epitope tags C-terminally to the HIV-2
protease recognition motif (FLAG) and N-terminally to the SsrA
tag (c-myc), we were able to monitor the amount of ClpP2 by
immunoblotting. As shown in Figure 3B, induction of HIV-2
protease resulted in degradation of the majority of ClpP2 and
inhibited bacterial growth (Figure 3C). Using this system, we did
not observe cell death, perhaps due to incomplete inhibition, as
would be expected for a system where the protease targets itself.
Loss of ClpP2, as measured by immunoblotting, was rapid and
reached near completion within hours. Furthermore, the growth
defect was complemented by expression of Mtb clpP2 using a
constitutively active promoter. A similar approach with ClpP1 was
unsuccessful as extended C-terminal tagging was not tolerated,
and the ID tag was indiscriminately cleaved. Collectively, these
results confirm that both ClpP1 and ClpP2 are required for
Author Summary
Due to the significant and rapid rise in multidrug resistant
Mycobacterium tuberculosis (Mtb), there is an urgent need
to validate novel drug targets for the treatment of
tuberculosis. Here, we show that Clp protease is an ideal
potential target. Mtb encodes two ClpP genes, ClpP1 and
ClpP2, which associate together to form a single proteo-
lytic complex, referred to as ClpP1P2. Both proteins are
required for growth in vitro and in a mouse model of
infection. Depletion of either protein results in rapid death
of the bacteria. Interestingly, this is rare among bacteria,
most of which have only one ClpP gene that is dispensable
for normal growth. We also show that Clp protease plays
an important quality control role by clearing abnormally
produced proteins. As known antimycobacterial therapeu-
tics increase errors in protein synthesis, inhibitors of
ClpP1P2 protease in Mtb may prove synergistic with
already existing agents.
Importance of Clp Protease in Mycobacteria
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function together in the ClpP1P2 complex.
Mycobacterial Clp protease plays a role in protein quality
control
In other bacteria, Clp plays a role in degrading abnormal
proteins such as SsrA-tagged peptides that stall on the ribosome
[22]. To determine the importance of ClpP1P2 protease in the
degradation of misfolded proteins, we used antibiotics that alter
protein synthesis in distinct ways including chloramphenicol,
which blocks protein elongation without increasing mistranslation
rates [23], and streptomycin and amikacin, which induce
translational errors resulting in missesnse or prematurely-termi-
nated polypeptides [24]. We found that the strain ptet_ClpP2, in
which clpP2 expression is regulated by anhydrotetracycline, grows
well in low or high concentrations of ATc, 1 to 100 ng/mL
(Figure 4A). Treatment with sublethal concentrations of chlor-
amphenicol resulted in no difference in viability between bacteria
maintained on low or high concentrations of ATc (Figure 4A,
bottom). In contrast, sub-MIC concentrations of the aminogly-
cosides streptomycin and amikacin significantly inhibited the
growth of strains incubated in low concentrations of ATc, while
they had no effect on growth of the strain maintained in high
concentrations of ATc (Figure 4A, top). Together, these results
suggest that ClpP1P2 protease protects against error-prone
translation by catalyzing the degradation of misfolded proteins.
To specifically assess whether ClpP1P2 is responsible for the
removal of SsrA-tagged proteins in mycobacteria, we fused the
mycobacterial SsrA-tag to the C-terminus of GFP (GFP-SsrA) and
expressed the construct constitutively on an episomal plasmid.
This construct was introduced into the strain clpP2_ID, in which
ClpP2 degradation was regulated. In the presence of ClpP2 (and in
wild type cells), there was no detectable GFP-SsrA. However,
upon depletion of ClpP2, there was substantial accumulation of
GFP-SsrA, as measured by both fluorescence and immunoblot
analysis after four hours (Figure 4B, 4C). Quantitative PCR
Figure 1. Mtb ClpP1 and ClpP2 interact, forming a multi-component protease, and share substantial similarity with ClpP1 and
ClpP2 homologs in Msm. (A) C-terminally myc-tagged Mtb ClpP1 and 66His-tagged Mtb ClpP2 were expressed in Msm. Lysate (lane 1) was
prepared and loaded onto a Ni-column. After washing with PBS (lanes 2,3), Ni-bound material was eluted with 50 mM (lane 4), 100 mM (lane 5),
250 mM (lane 6, 7) of imidazole in PBS, and analyzed by immunoblotting using anti a-myc and a-66His antibodies. (B) Fraction 6 from (A) was applied
to an anti-myc column (lane 1). The flow through (lane 2), and bound material (lane 3) were analyzed by immunoblot with a-myc and a-His
antibodies. Bound material was released from the anti-myc agarose beads by boiling in Laemmli buffer after washing with PBS. (C) Bands
representing ClpP1 and ClpP2 from (B) were sequenced by MS/MS revealing the presence of both Mtb and Msm homologs. Msm specific peptides are
indicated by black lines, those specific to Mtb are indicated by red lines. (D) Cleavage of fluorescent peptide Z-Gly-Gly-Leu-AMC was measured in the
presence of 1 mg ClpP1, 1 mg Clp2, and the activating peptide Z-Leu-Leu (see accompanying paper). Addition of 5 mg of catalytically inactive mutants
of either ClpP1 (ClpP1S) or ClpP2 (ClpP2S) markedly inhibited cleavage by the ClpP1P2 protease. Results graphed are a representative sample of
results obtained.
doi:10.1371/journal.ppat.1002511.g001
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activation of the gene (Figure S2). GFP lacking the SsrA tag is
present at similar levels in all strains (data not shown). Because we
cannot detect GFP-SsrA in the presence of Clp activity, we were
unable to accurately measure changes in protein stability.
However, the rate of accumulation of GFP-SsrA was consistent
with the time course of ClpP2 depletion, which occurred over six
hours, as shown by immunoblotting. Thus, functional ClpP1P2
protease is vital for the rapid clearance of SsrA-tagged substrates in
mycobacteria.
Functional Clp protease is required for growth of Mtb in
vitro and during infection
As shown above, catalytically inactive forms of ClpP1 and
ClpP2 inhibit proteolysis by the wild type enzyme, possibly by
replacement of wild type subunits with inactive ones. To assess
whether ClpP1P2 activity is required for the growth of Mtb, we
expressed a catalytically inactive form of Mtb clpP1, clpP1 S98A,o n
a tetracycline-inducible plasmid in wild type Mtb. Addition of ATc
led to expression of the catalytically inactive mutant protein and
resulted in a significant inhibition of growth (Figure 5A) while
overexpression of wild type Mtb clpP1 had no effect.
To determine if the dominant negative mutant of ClpP1
affected ClpP1P2 function during infection, we infected mice with
a 3:1 mixture of Mtb expressing clpP1 S98A on a hygromycin-
resistant doxycycline inducible plasmid and wild type Mtb
(containing a kanamycin-resistant control vector). Mice were fed
either normal chow or chow infused with the inducer doxycycline.
Growth of Mtb was monitored by assessing CFU in lung tissue at
day 30 post-infection. While there were no differences in the
growth of wild type Mtb between treated and untreated mice,
expression of the active site mutant significantly inhibited growth
(Figure 5B). Our results suggest that functional ClpP1P2 protease
is required for the growth of Mtb both in vitro and during infection.
Discussion
We find that the mycobacterial ClpP1P2 protease has two
unusual properties that distinguishes it from other members of the
Figure 2. Both ClpP1 and ClpP2 are essential for normal growth in mycobacteria. (A) Schematic representation of mycobacterial
recombineering, employed to replace the endogenous promoter of the clpP1P2 operon with a ATc-inducible promoter (Msm strain ptet_clpP1P2). (B)
Growth curves of Msm ptet_clpP1P2 in the presence (50 ng/mL) or absence of inducer ATc. Data are represented as mean CFU/mL +/2 standard
deviation. (C) Growth curves of Msm ptet_clpP1P2 complemented with clpP1, clpP2 or both clpP1 and clpP2 in the absence of inducer ATc. Data are
represented as mean CFU/mL +/2 standard deviation. (D) Schematic representation of genetic strategy used to create a tetracycline inducible
conditional Msm ClpP2 mutant (Msm strain ptet_ClpP2) (E) Growth curves of Msm ptet_clpP2 in the presence (50 ng/mL) or absence of inducer ATc.
Msm ptet_clpP2 was also complemented with clpP2 in the absence of ATc. Data are represented as mean OD600 +/2 standard deviation. Dashed
lines represent assumed growth rates until first measured growth point.
doi:10.1371/journal.ppat.1002511.g002
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types of subunits, each of which is required for full activity of a
single proteolytic complex. While other species do encode multiple
ClpP subunits, two different proteolytic subunits forming a single
protease has not been documented. Second, unlike in most
bacteria that have been studied, ClpP1P2 activity is absolutely
required for normal growth. This requirement is particularly
striking as mycobacteria contain several cytoplasmic ATP-
dependent proteolytic complexes, including FtsH, and the
proteasome [7,25,26]. Clearly, the mycobacterial ClpP1P2
proteolytic core has unique roles that are important for viability.
The ClpP proteases that have been characterized biochemically
in other bacteria and mitochondria are tetradecameric complexes
containing a single type of proteolytic subunit. In mycobacteria,
however, two different protein species contribute to protease
activity. Although Mtb ClpP1 forms a tetradecameric complex, a
crystal structure of Mtb ClpP1 lacks appropriate active site
geometry to support proteolysis [27]. The presence of two ClpP
subunits with distinct substrate preferences may facilitate an
expansion of the peptide specificity of the complex, much like the
eukaryotic proteasome. Interestingly, the Mtb proteasome is
composed of a single type of subunit, and the presence of distinct
subunits comprising a single proteolytic core is rare among
prokaryotes.
There is at least one example of an essential role for ClpP. In
Caulobacter crescentus, ClpXP degrades CtrA, a protein that normally
inhibits cell cycle progression during cellular replication [28]. In
this case, a single protein target is responsible for the essentiality of
the enzyme. ClpP1P2 protease might play a similar role in
mycobacteria. While this may be true, screens for essential
proteins in mycobacteria suggest that, in addition to the clpP1 and
clpP2, multiple Clp-associated ATPase adapters (clpX and clpC1)
are also essential [18]. The requirement of multiple adapters
makes it possible that accumulation of multiple protein substrates
contribute to the poor growth phenotype observed on depleting
the ClpP1 and ClpP2 subunits in mycobacteria.
ClpP1P2 might be important for other reasons. As shown here,
ClpP1P2 protease is required for the clearance of SsrA-tagged
proteins. These tagged polypeptides are generated under condi-
tions when protein synthesis is stalled and are required for
ribosome release. In the absence of ClpP1P2-mediated proteolysis,
protein synthesis might eventually be inhibited. In addition,
ClpP1P2 protease is necessary for degrading abnormal proteins,
such as those produced in the presence of certain antibiotics.
Accumulation of such non-functional misfolded proteins might
result in cellular stress in the absence of an effective system for
their removal [29]. Clearance of damaged proteins might be
particularly important in Mtb during infection, when cells are
exposed to multiple oxidative and nitrosoative radicals that can
induce protein damage. In fact, a transcriptional activator of the
clpP1P2 operon, clgR, is critically activated upon reaeration of
hypoxic Mtb and during Mtb growth within the macrophage
[30,31]. Degradation of pre-existing proteins during such stressful
transitions may be the initial event that triggers adaptation and
facilitates the bacterium’s ability to handle a wide array of
environmental challenges. Using a dominant negative overexpres-
sion mutant in Mtb, we have confirmed that optimal Clp
proteolytic activity is required for growth during infection.
The essential nature of ClpP1P2 protease makes it an attractive
target for antibiotic development, particularly because the
proteases as a class are druggable enzymes and have already
been validated as therapeutic targets in the treatment of HIV,
hepatitis, and cancer [32]. In organisms where ClpP is not
essential, uncontrolled activation of ClpP activity can be toxic. For
example, in E. coli, acyldepsipeptide compounds reorganize the
ClpP proteolytic core, causing dissociation from ATPase adapters,
and indiscriminate protein degradation [33]. Compounds that
produce a similar effect should result in toxicity in a broad range of
Figure 3. Inducible protein degradation demonstrates requirement of ClpP2 for normal growth. (A) Schematic representation of the
inducible degradation system used to inducibly deplete ClpP2 (Msm strain clpP2_ID). Induction of HIV-2 protease with ATc leads to cleavage of the
HIV-2 protease cutting site and exposure of a SsrA tag on the tagged protein. Cleavage by HIV-2 protease and subsequent degradation can be
tracked via the FLAG (square) and c-myc (circle) epitope tags, respectively, included on the inducible degradation tag. (B) Degradation of ClpP2 in
clpP2_ID was tracked by Western in the absence or presence of inducer ATc. Blots were probed a-FLAG (loss indicates HIV-2 protease cleavage), a-
myc (loss indicates target degradation), and a-RpoB (loading control). (C) Growth curves of Msm clpP2_ID in the absence or presence (50 ng/mL) of
inducer ATc. Msm clpP2_ID was also complemented with clpP2 in the presence of ATc. Data are represented as mean CFU/mL +/2 standard
deviation.
doi:10.1371/journal.ppat.1002511.g003
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product cyclomarin kills Mtb by targeting the ClpC1 ATPase and
presumably increasing Clp-mediated proteolysis, as demonstrated
in a whole cell fluorescence-based assay [34]. In mycobacteria,
where ClpP1P2 protease activity is required and depletion of
either subunit is bactericidal, either non-specific activation or
inhibition could effectively limit bacterial growth. An example of a
ClpP inhibitor with potential therapeutic activity already exists. In
S. aureus, beta-lactones have been found to inhibit Clp protease
activity and decrease the virulence of the organism [35].
Additionally, the synergistic nature of ClpP1P2 protease depletion
with aminoglycosides, a class of drugs already used to treat
tuberculosis, points to a potential combination therapy against
Mtb. As ClpP1P2 protease is most likely involved in preventing the
accumulation of misfolded proteins and the degradation of critical
endogenous regulatory proteins, small molecule modulators of
ClpP1P2 activity would target a critical aspect of Mtb physiology,
and might prove useful in the face of growing multi-drug resistance
in one of the world’s most successful pathogens.
Materials and Methods
Ethics statement
The animal experiments were preformed with protocols
approved by the Harvard Medical School Animal Management
Program, which is accredited by the Association for Assessment
Figure 4. Clp protease is required for degradation of abnormal proteins and SsrA-tagged proteins in mycobacteria. (A) Growth curves
of Msm ptet_clpP2 in growth medium containing low (1 ng/mL) or high (100 ng/mL) concentrations of inducer ATc, in the presence of either no
drug, or amikacin (top left, 0.03 mg/mL), streptomycin (top right, 0.125 mg/mL), and chloramphenicol (bottom, 7.5 mg/mL). Data are represented as
mean OD600 +/2 standard deviation. Dashed lines represent assumed growth rates until first measured growth point. (B) Increase in fluorescence
(RFU, 485/520) and initial growth curve (OD600) of Msm clpP2_ID expressing the fusion construct GFP-SsrA on a constitutively expressing plasmid, in
the presence and absence of inducer, ATc. Data are represented as mean RFU or OD600 +/2 standard deviation. (C) Depletion of ClpP2 and increase in
GFP-SsrA in Msm clpP2_ID expressing the fusion construct GFP-SsrA on a constitutively expressing plasmid was tracked by immunoblot. Blots were
probed a-GFP, a-myc, a-FLAG, and a-RpoB (loading control).
doi:10.1371/journal.ppat.1002511.g004
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(AAALAC) and meets National Institute of Health standards as set
forth in the Guide for the Care and Use of Laboratory Animals
(Revised, 2010). The institution also accepts as mandatory the
PHS Policy on Humane Care and Use of Laboratory Animals by
Awardee Institutions and NIH Principles for the Utilization and
Care of Vertebrate Animals Testing, Research, and Training. An
Animal Welfare Assurance of Compliance is on file with the Office
of Laboratory Animal Welfare (OLAW) (#A3431-01).
Bacterial strains and plasmids
Msm mc
2155 (Msm) or Mtb H37Rv were grown at 37uCi n
Middlebrook 7H9 broth with 0.05% Tween 80 and ADC (0.5%
BSA, 0.2% dextrose, 0.085% NaCl, 0.003 g catalase/1L media).
Mtb was additionally supplemented with oleic acid (0.006%). For
growth curves, overnight cultures were diluted into the appropri-
ate media and growth was either measured by OD600 or colony
forming units per mL. A summary of all strains, plasmids, and
primers used in this study as well as a summary of the construction
of conditional mutants can be found in the supporting information
(Text S1).
Protein purification and in vitro peptidase assay
The C-terminally 66His-tagged wild type clpP1, wild type clpP2,
clpP1Ser
98Ala, and clpP2Ser
110Ala subunits were overexpressed in
Msm using an anhydrotetracycline (ATc) inducible expression
system. After overnight induction with ATc (100 ng/mL), cells
were lysed by French press, and lysates were centrifuged for 1 h at
100,000 g. The subunits were purified from the supernatant by
Ni-NTA affinity chromatography (Qiagen). Eluted fractions
containing ClpP proteins were pooled and further purified by size
exclusion chromatography on Sephacryl S-300 column. Equal
amounts of ClpP1 and ClpP2 (1 mg each) were mixed in the
reaction buffer (50 mM K-phosphate buffer pH 7,5, 100 mM
KCl, 5% glycerol, 2 mM BME, 5 mM Z-Leu-Leu) and peptidase
activity was measured by a rise in fluorescence at 460 nm (Ex at
340 nm) with 0.1 mM Z-Gly-Gly-Leu-AMC as a substrate. To
measure dominant negative effect of active site mutants, same
reaction was carried out in the presence of 5 mg of the mutant
proteins.
Animal infections
Six to eight week old C57BL/6 mice (Jackson Laboratory) were
used for animal infections. Mice were infected via aerosolization
with 5610
6 CFU each of a 3:1 mixture of Mtb pTet::ClpP1 S98A
and Mtb pTet::GFP (wild type Mtb transformed with a control
pTet plasmid containing GFP ). Mice were fed with chow with or
without inducer doxycycline. At 30 days after infection, mice were
sacrificed, lungs were homogenized and appropriate dilutions were
plated on 7H10 plates containing hygromycin or kanamycin to
select for the Clp mutant or the control respectively.
Supporting Information
Figure S1 PCR confirmation of mycobacterial recombi-
neering. Primers specific to the 59-UTR and 39-UTR of the
clpP1P2 operon (RMR13 and RMR16, arrows) were used to
distinguish wildtype Msm (expected fragment: 1.8 kb), Msm
ptet_ClpP1P2 (expected size: 4.8 kb), and Msm clpP2_ID
(expected size 3.2 kb). For each construct, at least one primer
was outside homology region used for recombineering in order to
ensure specific insertion into the endogenous chromosome.
(TIF)
Figure S2 Increase in GFP-SsrA upon depletion of ClpP2
is not due to transcriptional activation of GFP-SsrA.
Quantitative PCR of clpP2_ID was carried out to determine if
Figure 5. A catalytically inactive ClpP allele inhibit Mtb growth in vitro and during infection. (A) Growth curves for Mtb overexpressing wild
type ClpP1 or ClpP1 S98A via an ATc-inducible expression vector. Data are represented as mean OD600 +/2 standard deviation. Dashed lines
represent assumed growth rates until first measured growth point. (B) Growth of Mtb containing a doxycycline-inducible plasmid expressing the
mutant allele ClpP1 S98A in lungs of C57BL/6 mice 30 days post aerosol infection. Mice were infected via aerosol with a 3:1 mixture of mutant and
wild type bacteria. Mice were fed either with chow containing (dark squares, N=5 mice) or lacking (gray triangles, N=5 mice) the inducer
doxycycline. As a control, wild type Mtb was co-infected, and representative CFU/organs for the control are represented (right). Each point represents
calculated total CFU/organ for each mouse. Not all mice received enough wild type bacteria to quantitate.
doi:10.1371/journal.ppat.1002511.g005
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was isolated from clpP2_ID four hours after induction with ATc
(+ATc), and a culture of equal OD600 that was left uninduced
(2ATc). Using both sigA (left) and 16s rRNA (right) as
endogenous controls, there was no significant difference in
transcription of GFP-SsrA between induced and uninduced
cultures. Data are represented as mean fold change +/2 standard
deviation, with values normalized to those of the uninduced
culture.
(TIF)
Text S1 Supplementary methods.
(DOC)
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